Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
Blood
|
July 31, 2010
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Nicolas Chapuis, Sophie Park, Laurent Leotoing, et al.
Cancers
|
September 10, 2021
Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy
Guillemette Fouquet, Myriam Wartski, Amina Dechmi, et al.
Blood
|
April 12, 2007
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients
Jerome Tamburini, Caroline Elie, Valérie Bardet, et al.
British Journal of Haematology
|
September 11, 2018
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation
Anna Raimbault, Sigrid Machherndl-Spandl, Raphaël Itzykson, et al.
Leukemia & Lymphoma
|
August 29, 2020
Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy
Anne-Sophie Alary, Marguerite Vignon, Raphael Carapito, et al.
Haematologica
|
January 7, 2021
APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
Rudy Birsen, Clement Larrue, Justine Decroocq, et al.
Cytometry. Part B, Clinical Cytometry
|
June 26, 2024
Multicenter inter-laboratory quality control of monocyte HLA-DR expression by flow cytometry
Morgane Gossez, Benjamin Bonnet, Ismael Boussaid, et al.
Haematologica
|
February 1, 2015
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Valérie Bardet, Orianne Wagner-Ballon, Julien Guy, et al.
Haematologica
|
March 30, 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study
Natacha Johnson, Marie Templé, Chloe Friedrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2010
Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia
Nicolas Chapuis, Jerome Tamburini, Alexa S Green, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
Blood
|
July 31, 2010
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Nicolas Chapuis, Sophie Park, Laurent Leotoing, et al.
Cancers
|
September 10, 2021
Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy
Guillemette Fouquet, Myriam Wartski, Amina Dechmi, et al.
Blood
|
April 12, 2007
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients
Jerome Tamburini, Caroline Elie, Valérie Bardet, et al.
British Journal of Haematology
|
September 11, 2018
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation
Anna Raimbault, Sigrid Machherndl-Spandl, Raphaël Itzykson, et al.
Leukemia & Lymphoma
|
August 29, 2020
Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy
Anne-Sophie Alary, Marguerite Vignon, Raphael Carapito, et al.
Haematologica
|
January 7, 2021
APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
Rudy Birsen, Clement Larrue, Justine Decroocq, et al.
Cytometry. Part B, Clinical Cytometry
|
June 26, 2024
Multicenter inter-laboratory quality control of monocyte HLA-DR expression by flow cytometry
Morgane Gossez, Benjamin Bonnet, Ismael Boussaid, et al.
Haematologica
|
February 1, 2015
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Valérie Bardet, Orianne Wagner-Ballon, Julien Guy, et al.
Haematologica
|
March 30, 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study
Natacha Johnson, Marie Templé, Chloe Friedrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2010
Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia
Nicolas Chapuis, Jerome Tamburini, Alexa S Green, et al.
Page
of 10